In line with these findings, in the present study, we showed that TNFα but not IL-1β or IL-6, all found to be induced in the setting of MASLD [17], decreased hepatic ADH activity. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.